We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+9.31%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$273B
AUM Growth
+$20.9B
Cap. Flow
+$2.91B
Cap. Flow %
1.06%
Top 10 Hldgs %
16.06%
Holding
3,565
New
168
Increased
2,233
Reduced
898
Closed
80

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$892M
2
MRK icon
Merck
MRK
+$858M
3
AMGN icon
Amgen
AMGN
+$857M
4
HD icon
Home Depot
HD
+$837M
5
CSCO icon
Cisco
CSCO
+$781M

Top Sells

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$776M
2
UPS icon
United Parcel Service
UPS
+$615M
3
QCOM icon
Qualcomm
QCOM
+$587M
4
BABA icon
Alibaba
BABA
+$555M
5
ETN icon
Eaton
ETN
+$508M

Sector Composition

Rank Sector Weight
1 Technology 19.68%
2 Financials 12.96%
3 Healthcare 11.88%
4 Consumer Discretionary 11.22%
5 Industrials 9.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EPAY
1826
DELISTED
Bottomline Technologies Inc
EPAY
$12.5M ﹤0.01%
277,134
+7,356
+3% +$354K
KURA icon
1827
Kura Oncology
KURA
$816M
$12.5M ﹤0.01%
443,227
+21,588
+5% +$683K
RVNC
1828
DELISTED
Revance Therapeutics, Inc.
RVNC
$12.5M ﹤0.01%
446,941
+35,910
+9% +$993K
VRRM icon
1829
Verra Mobility
VRRM
$852M
$12.5M ﹤0.01%
922,881
+27,847
+3% +$386K
RCKT icon
1830
Rocket Pharmaceuticals
RCKT
$372M
$12.5M ﹤0.01%
281,379
+20,843
+8% +$1.14M
TTEC icon
1831
TTEC Holdings
TTEC
$122M
$12.5M ﹤0.01%
124,137
+4,270
+4% +$362K
RKT icon
1832
Rocket Companies
RKT
$38.7B
$12.5M ﹤0.01%
539,990
+15,974
+3% +$357K
AXNX
1833
DELISTED
Axonics, Inc. Common Stock
AXNX
$12.5M ﹤0.01%
207,940
+12,051
+6% +$655K
LSXMA
1834
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$12.4M ﹤0.01%
384,140
-40,634
-10% -$1.3M
VIRT icon
1835
Virtu Financial
VIRT
$5.2B
$12.4M ﹤0.01%
399,800
+16,331
+4% +$450K
SHC icon
1836
Sotera Health
SHC
$5.13B
$12.4M ﹤0.01%
+496,482
New +$13.1M
MTSC
1837
DELISTED
MTS Systems Corp
MTSC
$12.4M ﹤0.01%
212,223
+5,077
+2% +$297K
BCRX icon
1838
BioCryst Pharmaceuticals
BCRX
$2.24B
$12.3M ﹤0.01%
1,206,966
+38,275
+3% +$395K
TPIC
1839
DELISTED
TPI Composites
TPIC
$12.3M ﹤0.01%
217,477
+8,908
+4% +$536K
MRC
1840
DELISTED
MRC Global
MRC
$12.3M ﹤0.01%
1,357,113
+6,501
+0.5% +$55.3K
PRSU
1841
Pursuit Attractions and Hospitality Inc
PRSU
$1.41B
$12.3M ﹤0.01%
293,393
+10,390
+4% +$412K
USNA icon
1842
Usana Health Sciences
USNA
$422M
$12.2M ﹤0.01%
125,349
-11,575
-8% -$1.05M
SCHL icon
1843
Scholastic
SCHL
$794M
$12.2M ﹤0.01%
405,309
+7,928
+2% +$223K
DCPH
1844
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$12.1M ﹤0.01%
270,384
+11,151
+4% +$519K
GBT
1845
DELISTED
Global Blood Therapeutics, Inc.
GBT
$12.1M ﹤0.01%
296,951
-18,412
-6% -$846K
AAMI
1846
Acadian Asset Management
AAMI
$3.2B
$12.1M ﹤0.01%
592,685
+6,131
+1% +$121K
TRS icon
1847
TriMas Corp
TRS
$1.45B
$12M ﹤0.01%
394,617
+6,526
+2% +$215K
VICR icon
1848
Vicor
VICR
$9.85B
$12M ﹤0.01%
140,706
+4,489
+3% +$423K
TFIN icon
1849
Triumph Financial Inc
TFIN
$1.83B
$11.9M ﹤0.01%
154,206
+4,677
+3% +$325K
CSR
1850
Centerspace
CSR
$932M
$11.9M ﹤0.01%
175,457
+5,080
+3% +$363K

Similar funds

Charles Schwab's Q1 2021 Portfolio in Review

As of Q1 2021, Charles Schwab held 3,565 positions worth $273B, up 8.3% from $252B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Charles Schwab's Q1 2021 filing shows 168 new, 2,233 increased, 898 reduced and 80 closed positions. Its largest new stake was State Street Financial Select Sector SPDR ETF: 6,984,918 shares worth $238M. The largest sale was ExxonMobil, an estimated $776M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q1 2021 buy was State Street Financial Select Sector SPDR ETF: 6,984,918 shares worth $238M.
  • Charles Schwab added most to Broadcom in Q1 2021, an estimated $892M increase.
  • Charles Schwab's biggest Q1 2021 reduction was ExxonMobil, cutting an estimated $776M.
  • Charles Schwab fully exited Invesco QQQ Trust in Q1 2021, selling an estimated $396M.
  • Charles Schwab's ten largest holdings make up 16% of its $273B portfolio in Q1 2021.
  • Charles Schwab opened 168 new positions and closed 80 in Q1 2021.
  • Charles Schwab's portfolio value rose 8.3% quarter-over-quarter to $273B.

Based on Charles Schwab's 13F filing for Q1 2021, filed 17 May 2021.